Skip to content
Clinical Trials – home
Stealth Biotherapeutics Inc.
Sponsor

Stealth Biotherapeutics Inc.

United States 123 Highland Avenue Suite 201, 02494-3005, United States

About the sponsor

Stealth Biotherapeutics Inc. is engaged in clinical research focused on dry age-related macular degeneration, a progressive retinal disorder affecting central vision and macular structure.

  • Dry Age-Related Macular Degeneration
  • Retinal Disease
  • Macular Degeneration

The sponsor’s research interest centers on vision-related outcomes and the treatment of degenerative eye conditions with unmet therapeutic need.

About Specializations

Stealth Biotherapeutics Inc. runs clinical trials in conditions such as Barth syndrome, Dry age-related macular degeneration, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Elamipretide Trihydrochloride
  • Sponsor:Stealth Biotherapeutics Inc.
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Elamipretide Trihydrochloride
  • Sponsor:Stealth Biotherapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.